The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.
The Generic Oncology Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Generic Oncology Drugs Market:
https://www.thebusinessresearchcompany.com/report/generic-oncology-drugs-global-market-report
According to The Business Research Company’s Generic Oncology Drugs Global Market Report 2024, The generic oncology drugs market size has grown strongly in recent years. It will grow from $25.64 billion in 2023 to $27.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to patent expirations, healthcare cost containment, increased cancer prevalence, health insurance coverage, physician prescribing practices.The generic oncology drugs market size is expected to see strong growth in the next few years. It will grow to $35.54 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.
The increasing demand for personalized medicine is expected to drive the growth of the generic oncology drugs market. Personalized medicine is an evolving medical approach that tailors treatments to individual genetic, environmental, and lifestyle factors. Generic oncology drugs play a vital role in personalized medicine by offering cost-effective alternatives customized to each patient’s needs, thus expanding access to specialized cancer treatments. For example, in September 2021, the Swedish Government allocated SEK 220 million ($1.87 million) to enhance the national infrastructure of Genomic Medicine Sweden (GMS). This investment aims to integrate precision medicine into the Swedish healthcare system, ensuring widespread access to precise tests and individualized care in response to the rising demand for personalized medicines. Therefore, the increasing demand for personalized medicine is fueling the growth of the generic oncology drugs market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12174&type=smp
The generic oncology drugs market covered in this report is segmented –
1) By Molecule Type: Large Molecule, Small Molecule
2) By Route of Administration: Oral, Parenteral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Managed Care Institutions
Top Major Players
Pfizer Inc.,
AbbVie,
Novartis AG,
Bristol-Myers Squibb Company,
AstraZeneca PLC
The generic oncology drugs market report table of contents includes:
1. Executive Summary
- Generic Oncology Drugs Market Characteristics
- Generic Oncology Drugs Market Trends And Strategies
- Generic Oncology Drugs Market – Macro Economic Scenario
- Global Generic Oncology Drugs Market Size and Growth
- Generic Oncology Drugs Market Segmentation
- Generic Oncology Drugs Market Regional And Country Analysis
………………….
- Key Mergers And Acquisitions In The Generic Oncology Drugs Market
- Generic Oncology Drugs Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Generic Oncology Drugs Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Generic Oncology Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Generic Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………………..
Table 74: Pfizer Inc. Financial Performance
Table 75: AbbVie Financial Performance
Table 76: Novartis AG Financial Performance
Table 77: Bristol-Myers Squibb Company Financial Performance
Table 78: AstraZeneca Plc Financial Performance
Read Related Reports :
https://topprnews.com/cattle-feeds-market-statistics/
https://goodprnews.com/cattle-feeds-market-trends/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
